Cellvax SAS, French SME founded in 2001, is a service company (CRO) which provides complete preclinical innovating services allowing accelerating the drug development process, mainly in Oncology and Osteoarthritis fields.

Competitive advantages, networking, Original animal models in rodents & non-rodents (Mice, Rats, Hamsters, Guinea pigs, Rabbits, Cats, Dogs, …); Numerous technical platforms, Reactivity, Confidentiality, Reliability, Track records of our founder team, …


  • Test in vitro
  • Primary tumor cells
  • Nodule syste
  • Animal models, S.C.
  • orthotopic tumor models
  • Metastasis
  • Angiogenesis


  • Animal models
    (mice, rats, rabbits,
    Guinea pigs, dogs, etc.)
  • Induced OA
  • ACLT model
  • Spontaneous OA model


  • PK/PD studies in both
    rodents and non-rodents

More information about Cellvax services

Find more about our service and in vivo or in vitro model offers in our corporate presentation. Feel free to contact us for your needs.